Cargando…
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
While SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) as the receptor for cell entry, it is important to examine other potential interactions between the virus and other cell receptors. Based on the clinical observation of low prevalence of smoking among hospitalized COVID-19 patients, we exa...
Autores principales: | Farsalinos, Konstantinos, Eliopoulos, Elias, Leonidas, Demetres D., Papadopoulos, Georgios E., Tzartos, Socrates, Poulas, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461543/ https://www.ncbi.nlm.nih.gov/pubmed/32823591 http://dx.doi.org/10.3390/ijms21165807 |
Ejemplares similares
-
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
por: Alexandris, Nikolaos, et al.
Publicado: (2020) -
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins
por: Lagoumintzis, George, et al.
Publicado: (2021) -
COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
por: Tanmay, Saraiya, et al.
Publicado: (2021)